JDM  Vol.5 No.2 , May 2015
Insulin Release from the Beta Cells in Acatalasemic Mice Is Highly Susceptible to Alloxan-Induced Oxidative Stress
Abstract: Background: Catalase deficiency (acatalasemia) is sensitive to alloxan, and the administration to acatalasemic mice develops hyperglycemia under mild conditions. However, the mechanism is still poorly understood. Methods: Alloxan was used to induce the oxidative stress and intraperitoneally administered to acatalasemic and normal mice. The blood samples of these mice after 1, 3, 5 and 7 days were examined. The pancreatic islets 7 days after alloxan administration were isolated, and the insulin released under 3 mM and 20 mM glucose was examined. Results: After alloxan administration, increase of oxidative markers in blood and pancreatic apoptosis in acatalasemic mice were observed immediately. Insulin in blood was lowered after 3 days, and the insulin in acatalasemic mice was lower than that in normal mice. Hyperglycemia in the acatalasemic mice was observed after 3 days. The pancreatic islets after 7 days were isolated. A reduction of the insulin released from the islets under glucose stimulation was observed. The stimulation indexes of the normal and acatalasemic mice were 1.4 ± 0.6 and 0.7 ± 0.3, respectively. Conclusions: Alloxan induced a deterioration of glucose-dependent insulin secretion ability from the islets, and the deterioration mostly contributed to hyperglycemia, rather than apoptosis.
Cite this paper: Takemoto, K. , Doi, W. , Kataoka, K. , Ishihara, K. , Wang, D. , Sugiyama, H. and Masuoka, N. (2015) Insulin Release from the Beta Cells in Acatalasemic Mice Is Highly Susceptible to Alloxan-Induced Oxidative Stress. Journal of Diabetes Mellitus, 5, 81-89. doi: 10.4236/jdm.2015.52010.

[1]   Wang, D.H., Masuoka, N. and Kira, S. (2003) Animal Model for Oxidative Stress Research―Catalase Mutant Mice. Environmental Health and Preventive Medicine, 8, 37-40.

[2]   Takahara, S. and Miyamoto, H. (1948) Three Cases of Progressive Oral Gangrene Due to Lack of Catalase in the Blood. Nippon Jibiinkoka Gakkai Kaiho, 51, 163. (in Japanese)

[3]   Aebi, H.E. and Wyss, S.R. (1978) Acatalasemia. In: Stanbury, J.B., Wyngaarden, J.B. and Fredricson, S., Eds., The Metabolic Basis of Inherited Disease, 4th Edition, Mcgraw-Hill, New York, 1792-1807.

[4]   Goth, L. and Eaton, J.W. (2000) Hereditary Catalase Deficiencies and Increase Risk of Diabetes. The Lancet, 354, 1820-1821.

[5]   Feinstein, R.N., Braun, J.T. and Howard, J.B. (1967) Acatalasemic and Hypocatalasemic Mouse Mutants: II. Mutational Variations in Blood and Solid Tissue Catalases. Archives of Biochemistry and Biophysics, 120, 165-169.

[6]   Takemoto, K., Tanaka, M., Iwata., H, Nishihara, R., Ishihara, K., Wang, D.H., Ogino, K., Taniuchi, K. and Masuoka, N. (2009) Low Catalase Activity in Blood Is Associated with the Diabetes Caused by Alloxan. Clinica Chimica Acta, 407, 43-46.

[7]   Kikumoto, Y., Sugiyama, H., Inoue, T., Morinaga, H., Takiue, K., Kitagawa, M., Fukuoka, N., Saeki, M., Maeshima, Y., Wang, D.H., Ogino, K., Masuoka, N. and Makino, H. (2010) Sensitization to Alloxan-Induced Diabetes and Pancreatic Cell Apoptosis in Acatalasemic Mice. Biochimica et Biophysica Acta, 1802, 240-246.

[8]   Kamimura, W., Doi, W., Takemoto, K., Ishihara, K., Wang, D.H., Sugiyama, H., Oda, S. and Masuoka, N. (2013) Effect of Vitamin E on Alloxan-Induced Mouse Diabetes. Clinical Biochemistry, 46, 795-798.

[9]   Takemoto, K., Doi, W., Zukeran, A., Inoue, J., Ishihara, K. and Masuoka, N. (2014) Effect of Aspergillus awamori-Fermented Burdock Root on Mouse Diabetes Induced by Alloxan—Prevention of Cell Apoptosis. Food and Nutrition Sciences, 5, 1554-1560.

[10]   Szkudelski, T. (2001) The Mechanism of Alloxan and Streptozotocin Action in B Cells of the Rat Pancreas. Physiological Research, 50, 537-546.

[11]   Lenzen, S. (2008) The Mechanisms of Alloxan-and Streptozotocin-Induced Diabetes. Diabetologia, 51, 216-226.

[12]   Cnop, M., Welsh, N., Jonas, J.C., Jorns, A., Lenzen, S. and Eizirik, D.L. (2005) Mechanism of Pancreatic Beta-Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few Similarities. Diabetes, 54, S97-S107.

[13]   Masuoka, N., Wakimoto, M., Ubuka, T. and Nakano, T. (1996) Spectrophotometric Determination of Hydrogen Peroxide: Catalase Activity and Rates of Hydrogen Peroxide Removal by Erythrocytes. Clinica Chimica Acta, 254, 101-112.

[14]   Gao, D., Li, Q., Liu, Z., Li, Y., Liu, Z., Fan, Y., Li, K., Han, Z. and Li, J. (2007) Hypoglycemic Effects and Mechanisms of Action of Cortex Lycii Radicis on Alloxan-Induced Diabetic Mice. Yakugaku Zasshi, 127, 1715-1721.

[15]   Nam, S.Y., Lee, M.K. and Sabapathy, K. (2008) The Tumour-Suppressor p53 Is Not Required for Pancreatic Beta Cell Death during Diabetes and upon Irradiation. The Journal of Physiology, 586, 407-417.

[16]   Zhang, N., Komine-Kobayashi, M., Tanaka, R., Liu, M., Mizuno, Y. and Urabe, T. (2005) Edaravone Reduces Early Accumulation of Oxidative Products and Sequential Inflammatory Responses after Transient Focal Ischemia in Mice Brain. Stroke, 36, 2220-2225.

[17]   Nakamura, A. and Goto, S. (1996) Analysis of Protein Carbonyls with 2,4-Dinitrophenyl Hydrazine and Its Antibodies by Immunoblot in Two-Dimensional Gel Electrophoresis. The Journal of Biochemistry, 119, 768-774.

[18]   Lacy, P.E. and Kostianovsky, M. (1967) Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas. Diabetes, 16, 35-39.

[19]   Sasamoto, H., Futami, M., Ando, Y. and Nakaji, S. (2012) Cryopreservation of Rat Islets of Langerhans by Vitrification. Journal of Artificial Organs, 15, 283-289.

[20]   Rebelato, E., Abdalkadel, F., Curi, R. and Carpinelli, A.R. (2011) Control of the Intracellular Redox State by Glucose Participates in the Insulin Secretion Mechanism. PLoS ONE, 6, e24507.